Modulation of TMEM16B channel activity by the calcium-activated chloride channel regulator 4 (CLCA4) in human cells
Open Access
- 31 May 2024
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (7) , 107432
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- TMEM16A (ANO1) as a therapeutic target in cystic fibrosisCurrent Opinion in Pharmacology, 2022
- Involvement of TMEM16A/ANO1 upregulation in the oncogenesis of colorectal cancerBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2022
- Structure–Function of TMEM16 Ion Channels and Lipid Scramblases2021
- Structural and Biophysical Analysis of the CLCA1 VWA Domain Suggests Mode of TMEM16A EngagementCell Reports, 2020
- Calcium-activated chloride channel regulator 1 (CLCA1): More than a regulator of chloride transport and mucus productionWorld Allergy Organization Journal, 2019
- Inhibition of Ca2+‐activated chloride channel ANO1 suppresses ovarian cancer through inactivating PI3K/Akt signalingInternational Journal of Cancer, 2019
- Anoctamin2 (TMEM16B) forms the Ca2+-activated Cl− channel in the retinal pigment epitheliumExperimental Eye Research, 2017
- Biomarkers of human gastrointestinal tract regionsMammalian Genome, 2009
- The CLCA gene locus as a modulator of the gastrointestinal basic defect in cystic fibrosisHuman Genetics, 2004
- A Practical Guide to the Preparation of Ca2+ Buffers1994